107 related articles for article (PubMed ID: 24679674)
1. Pharmacological characterization of actin-binding (-)-doliculide.
Foerster F; Braig S; Chen T; Altmann KH; Vollmar AM
Bioorg Med Chem; 2014 Sep; 22(18):5117-22. PubMed ID: 24679674
[TBL] [Abstract][Full Text] [Related]
2. Actin-binding doliculide causes premature senescence in p53 wild type cells.
Foerster F; Chen T; Altmann KH; Vollmar AM
Bioorg Med Chem; 2016 Jan; 24(2):123-9. PubMed ID: 26692350
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of (-)-doliculide, structure-activity relationship studies and its binding to F-actin.
Matcha K; Madduri AV; Roy S; Ziegler S; Waldmann H; Hirsch AK; Minnaard AJ
Chembiochem; 2012 Nov; 13(17):2537-48. PubMed ID: 23129522
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-cancer effects of the actin-binding natural compound rhizopodin.
Zhang S; Menche D; Zahler S; Vollmar AM; Liebl J; Förster F
Pharmazie; 2015 Sep; 70(9):610-5. PubMed ID: 26492647
[TBL] [Abstract][Full Text] [Related]
5. (-)-Doliculide, a new macrocyclic depsipeptide enhancer of actin assembly.
Bai R; Covell DG; Liu C; Ghosh AK; Hamel E
J Biol Chem; 2002 Aug; 277(35):32165-71. PubMed ID: 12077149
[TBL] [Abstract][Full Text] [Related]
6. Targeting the actin cytoskeleton: selective antitumor action via trapping PKCɛ.
Foerster F; Braig S; Moser C; Kubisch R; Busse J; Wagner E; Schmoeckel E; Mayr D; Schmitt S; Huettel S; Zischka H; Mueller R; Vollmar AM
Cell Death Dis; 2014 Aug; 5(8):e1398. PubMed ID: 25165884
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity correlation of natural-product inspired cyclodepsipeptides stabilizing F-actin.
Tannert R; Milroy LG; Ellinger B; Hu TS; Arndt HD; Waldmann H
J Am Chem Soc; 2010 Mar; 132(9):3063-77. PubMed ID: 20148556
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis and biological evaluation of jerantinine E.
Frei R; Staedler D; Raja A; Franke R; Sasse F; Gerber-Lemaire S; Waser J
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13373-6. PubMed ID: 24127420
[No Abstract] [Full Text] [Related]
9. Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide.
Terracciano S; Bruno I; D'Amico E; Bifulco G; Zampella A; Sepe V; Smith CD; Riccio R
Bioorg Med Chem; 2008 Jul; 16(13):6580-8. PubMed ID: 18508272
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the activities of actin-affecting drugs on tumor cell migration.
Hayot C; Debeir O; Van Ham P; Van Damme M; Kiss R; Decaestecker C
Toxicol Appl Pharmacol; 2006 Feb; 211(1):30-40. PubMed ID: 16005926
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects of dillapiole on MDA-MB-231 cells involve the induction of apoptosis through the mitochondrial pathway by inducing an oxidative stress while altering the cytoskeleton network.
Ferreira AK; de-Sá-Júnior PL; Pasqualoto KF; de Azevedo RA; Câmara DA; Costa AS; Figueiredo CR; Matsuo AL; Massaoka MH; Auada AV; Lebrun I; Damião MC; Tavares MT; Magri FM; Kerkis I; Parise Filho R
Biochimie; 2014 Apr; 99():195-207. PubMed ID: 24355203
[TBL] [Abstract][Full Text] [Related]
12. The geodiamolide H, derived from Brazilian sponge Geodia corticostylifera, regulates actin cytoskeleton, migration and invasion of breast cancer cells cultured in three-dimensional environment.
Freitas VM; Rangel M; Bisson LF; Jaeger RG; Machado-Santelli GM
J Cell Physiol; 2008 Sep; 216(3):583-94. PubMed ID: 18330887
[TBL] [Abstract][Full Text] [Related]
13. Cytoskeleton alterations induced by Geodia corticostylifera depsipeptides in breast cancer cells.
Rangel M; Prado MP; Konno K; Naoki H; Freitas JC; Machado-Santelli GM
Peptides; 2006 Sep; 27(9):2047-57. PubMed ID: 16843570
[TBL] [Abstract][Full Text] [Related]
14. Discovery and biological activity of new chondramides from Chondromyces sp.
Herrmann J; Hüttel S; Müller R
Chembiochem; 2013 Sep; 14(13):1573-80. PubMed ID: 23959765
[TBL] [Abstract][Full Text] [Related]
15. Dolastatin 11 conformations, analogues and pharmacophore.
Ali MA; Bates RB; Crane ZD; Dicus CW; Gramme MR; Hamel E; Marcischak J; Martinez DS; McClure KJ; Nakkiew P; Pettit GR; Stessman CC; Sufi BA; Yarick GV
Bioorg Med Chem; 2005 Jul; 13(13):4138-52. PubMed ID: 15878670
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Late-Stage Modification of (-)-Doliculide Derivatives Using Matteson's Homologation Approach.
Tost M; Kazmaier U
Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667782
[TBL] [Abstract][Full Text] [Related]
17. The chemical and biological potential of C ring modified triterpenoids.
Siewert B; Wiemann J; Köwitsch A; Csuk R
Eur J Med Chem; 2014 Jan; 72():84-101. PubMed ID: 24361521
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effects of a novel class rosin-derivatives with different mechanisms.
Xing Y; Zhang W; Song J; Zhang Y; Jiang X; Wang R
Bioorg Med Chem Lett; 2013 Jul; 23(13):3868-72. PubMed ID: 23707051
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and anti-tumor activity of paeonol and its derivatives].
Wang XJ; Liu JL; Wang JK
Yao Xue Xue Bao; 2012 Jan; 47(1):72-6. PubMed ID: 22493808
[TBL] [Abstract][Full Text] [Related]
20. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.
Schneider G; Reker D; Chen T; Hauenstein K; Schneider P; Altmann KH
Angew Chem Int Ed Engl; 2016 Sep; 55(40):12408-11. PubMed ID: 27605391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
